Updated July 2026 · 10 min read

Ketamine Analgosedation: The ICU Nurse's Deep Dive

Part of the ICU Pharmacology Hub — browse every related guide in one place.

Ketamine breaks the rules that every other sedative follows: it supports the blood pressure instead of dropping it, it preserves the airway drive instead of suppressing it, and it treats pain at doses far below where it sedates. Understand the mechanism and you understand why it keeps showing up on your unstable, hard-to-sedate patients.

How ketamine works: NMDA antagonism

The NMDA (N-methyl-D-aspartate) receptor is a glutamate-gated channel central to pain signaling, memory, and the "wind-up" sensitization that turns acute pain chronic. Ketamine blocks this receptor non-competitively. The result is a peculiar state called dissociative anesthesia: the patient's cortex is functionally disconnected from incoming sensory and limbic input, so they appear awake (eyes may be open, muscle tone preserved) yet are unresponsive, amnestic, and profoundly analgesic. That NMDA blockade is also why ketamine is such a good analgesic at doses well below sedation — it interrupts pain transmission and central sensitization directly, which is the basis for using it to reduce opioid requirements.

Ketamine has additional actions that shape its bedside profile: it inhibits the reuptake of catecholamines (driving its cardiovascular stimulation) and interacts with opioid and other receptors, contributing to analgesia. But NMDA antagonism is the headline that explains the dissociation and the anti-hyperalgesic effect.

Why it supports the blood pressure

This is ketamine's most clinically useful quirk. By inhibiting catecholamine reuptake, ketamine produces a centrally mediated sympathetic stimulation — heart rate, blood pressure, and cardiac output typically rise or stay stable after a dose. For the hypotensive, shocky, or hemodynamically fragile patient who cannot tolerate the vasodilation of propofol, that is a major advantage: you can achieve sedation or analgesia without dropping an already marginal pressure.

Preserved respiratory drive and bronchodilation

Unlike most sedatives, ketamine at usual doses tends to preserve respiratory drive and upper-airway reflexes, and it is a bronchodilator. That makes it attractive for procedural sedation and for sedating a patient you would rather not fully depress — and it is a particularly logical agent in severe bronchospasm/status asthmaticus, where the bronchodilation is a bonus.

Two dosing worlds: analgesia vs. dissociation

The single most important practical concept is that ketamine has two completely different personalities depending on the dose:

As a low-dose analgesic adjunct, ketamine shines in patients with opioid tolerance, refractory pain, or where you are trying to limit opioids — pairing it with an opioid like fentanyl can lower the total opioid dose and blunt hyperalgesia. As a dissociative sedative, it is a tool for the agitated, hard-to-sedate, or hemodynamically fragile patient where propofol or a benzodiazepine would be risky. Always follow your unit's specific concentration and dosing protocol; ranges vary widely by institution.

Emergence reactions: the classic downside

The trade-off for dissociation is the emergence phenomenon: as ketamine wears off, patients can experience vivid, sometimes frightening dreams, hallucinations, or a sense of floating and unreality. These are more common with higher (dissociative) doses, in adults, and with rapid emergence. Management is largely about the environment and expectation:

Other effects to anticipate include hypersalivation, increased intracranial and intraocular considerations in select patients, tachycardia, and — with the low-dose analgesic infusions — occasional dysphoria or dizziness that usually responds to slowing the rate.

Where ketamine fits in the sedation toolbox

Think of ketamine as the sedative that does the opposite of what your others do to the circulation and the airway. When propofol would tank the pressure and a benzodiazepine would over-suppress, ketamine offers sedation and analgesia that tend to protect hemodynamics and drive. That is why it appears as an adjunct in multimodal, opioid-sparing sedation strategies — see the broader ICU sedation & analgesia guide and the precedex vs. propofol comparison for how the agents complement each other.

Why CRNA students should know it cold

On the CRNA path, ketamine is a workhorse for induction in the hemodynamically unstable trauma or septic patient, for the severe asthmatic, and as a low-dose intraoperative infusion to cut opioid requirements and blunt chronic-pain wind-up. The mechanism you learn titrating an analgesic ketamine drip in the ICU — NMDA blockade, sympathetic support, preserved drive, emergence management — is the exact reasoning you will use choosing it in the OR. Few drugs reward mechanism-level understanding as directly.

Bottom line

Ketamine is an NMDA antagonist that sedates by dissociation and treats pain at sub-sedative doses, all while tending to support blood pressure and preserve respiratory drive. Use it low-dose to spare opioids and higher-dose to sedate the fragile patient, respect the catecholamine-depletion caveat and the ongoing airway risk, and manage emergence reactions with a calm environment and clear expectations.

This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify every dose independently.